FDA WARNING_LETTER - SEI Pharmaceuticals, Inc. - September 29, 2011

FDA WARNING_LETTER for SEI Pharmaceuticals, Inc. on September 29, 2011. Product: Food. Access full analysis and detailed observations.

View on Dashboard

One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.

Record Summary

FDA WARNING_LETTER for SEI Pharmaceuticals, Inc. on September 29, 2011. Product: Food. Access full analysis and detailed observations.

Violation Codes

21 CFR 111

21 CFR 111.255(a)

21 CFR 111.205(a)

21 CFR 111.453

21 CFR 111.403

21 CFR 111.303

21 CFR 111.103

21 U.S.C. 342(g)(1)

21 CFR 111.75(c)

21 CFR 111.27(d)

Get More Insights

Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.

1.5M+ regulatory data points

Real-time compliance monitoring

Interactive analytics dashboard

Looking for more records? Our platform provides access to thousands of similar regulatory documents with advanced search and filtering capabilities.

Record Information

Company

SEI Pharmaceuticals, Inc.

Inspection Date

September 29, 2011

Product Type

Food

Office

Florida District Office

People

Emma R. Singleton (District Director)

ID: 26d26877-46a3-44d3-b924-f4da538739c2

View on Dashboard

Transform Regulatory Data into Actionable Intelligence

Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.

Try KeyPedia Today

Explore our real use cases and discover our features in depth.

Subscribe to our newsletter

Get the latest updates and insights delivered to your inbox